Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer

被引：2

作者：

Adams, Alexandra M. ^{[1
]}

Vreeland, Timothy J. ^{[2
,3
]}

Newhook, Timothy E. ^{[4
]}

机构：

[1] Brooke Army Med Ctr, Dept Surg, San Antonio, TX USA

[2] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD USA

[3] Brooke Army Med Ctr, Dept Surg Oncol, San Antonio, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA

来源：

JOURNAL OF GASTROINTESTINAL CANCER | 2023年 / 54卷 / 04期

关键词：

Circulating tumor DNA; ctDNA; Colorectal cancer; Tumor marker; Personalized medicine; LIVER METASTASES; ADJUVANT FLUOROURACIL; RESECTION; MULTICENTER; SURVIVAL; MUTATION; CHEMOTHERAPY; RECURRENCE; OUTCOMES; THERAPY;

D O I：

10.1007/s12029-022-00888-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose Despite curative-intent treatment, recurrence is common for patients with colorectal cancer (CRC). Currently, prediction of disease recurrence and prognostication following surgery is based upon vague clinical factors and more precise and dynamic biomarkers for risk stratification and treatment decisions are urgently needed. Circulating tumor DNA (ctDNA) is a promising biomarker for patients undergoing treatment for resectable CRC. Methods In this review, we provide an overview of the data supporting current uses of ctDNA for CRC, including localized CRC and resectable colorectal liver metastases (CLM), as well as descriptions of important ongoing clinical trials using ctDNA in the care of patients with CRC. Results The detection of ctDNA following curative-intent therapy is associated with disease recurrence, and multiple trials are investigating its role in determining need and duration for adjuvant therapy for localized CRC. In addition, ctDNA reliably predicts prognosis for patients with CLM, with trials underway studying ctDNA-guided treatment sequencing and intensity. Conclusion The detection of ctDNA is a sensitive and dynamic biomarker for disease recurrence in CRC. Many investigations are underway into ctDNA's potential role in surveillance and treatment algorithms, and it has the potential to become a critical biomarker to determine individualized strategies for treatment sequencing, choice, and duration of therapies.

引用

页码：1071 / 1081

页数：11

共 47 条

[1]

Anandappa G, 2020, J CLIN ONCOL, V38

[2] Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study [J].

Andre, Thierry ;

de Gramont, Armand ;

Vernerey, Dewi ;

Chibaudel, Benoist ;

Bonnetain, Franck ;

Tijeras-Raballand, Annemilai ;

Scriva, Aurelie ;

Hickish, Tamas ;

Tabernero, Josep ;

Van Laethem, Jean Luc ;

Banzi, Maria ;

Maartense, Eduard ;

Shmueli, Einat ;

Carlsson, Goran U. ;

Scheithauer, Werner ;

Papamichael, Demetris ;

Moeehler, Marcus ;

Landolfi, Stefania ;

Demetter, Pieter ;

Colote, Soudhir ;

Tournigand, Christophe ;

Louvet, Christophe ;

Duval, Alex ;

Flejou, Jean-Francois ;

de Gramont, Aimery .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) :4176-+

[3] Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Argiles, G. ;

Tabernero, J. ;

Labianca, R. ;

Hochhauser, D. ;

Salazar, R. ;

Iveson, T. ;

Laurent-Puig, P. ;

Quirke, P. ;

Yoshino, T. ;

Taieb, J. ;

Martinelli, E. ;

Arnold, D. .

ANNALS OF ONCOLOGY, 2020, 31 (10) :1291-1305

[4] Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review [J].

Ballehaninna U.K. ;

Chamberlain R.S. .

Indian Journal of Surgical Oncology, 2011, 2 (2) :88-100

[5] Colon Cancer, Version 2.2021 [J].

Benson, Al B. ;

Venook, Alan P. ;

Al-Hawary, Mahmoud M. ;

Arain, Mustafa A. ;

Chen, Yi-Jen ;

Ciombor, Kristen K. ;

Cohen, Stacey ;

Cooper, Harry S. ;

Deming, Dustin ;

Farkas, Linda ;

Garrido-Laguna, Ignacio ;

Grem, Jean L. ;

Gunn, Andrew ;

Hecht, J. Randolph ;

Hoffe, Sarah ;

Hubbard, Joleen ;

Hunt, Steven ;

Johung, Kimberly L. ;

Kirilcuk, Natalie ;

Krishnamurthi, Smitha ;

Messersmith, Wells A. ;

Meyerhardt, Jeffrey ;

Miller, Eric D. ;

Mulcahy, Mary F. ;

Nurkin, Steven ;

Overman, Michael J. ;

Parikh, Aparna ;

Patel, Hitendra ;

Pedersen, Katrina ;

Saltz, Leonard ;

Schneider, Charles ;

Shibata, David ;

Skibber, John M. ;

Sofocleous, Constantinos T. ;

Stoffel, Elena M. ;

Stotsky-Himelfarb, Eden ;

Willett, Christopher G. ;

Gregory, Kristina M. ;

Gurski, Lisa A. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (03) :329-359

[6] Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [J].

Bettegowda, Chetan ;

Sausen, Mark ;

Leary, Rebecca J. ;

Kinde, Isaac ;

Wang, Yuxuan ;

Agrawal, Nishant ;

Bartlett, Bjarne R. ;

Wang, Hao ;

Luber, Brandon ;

Alani, Rhoda M. ;

Antonarakis, Emmanuel S. ;

Azad, Nilofer S. ;

Bardelli, Alberto ;

Brem, Henry ;

Cameron, John L. ;

Lee, Clarence C. ;

Fecher, Leslie A. ;

Gallia, Gary L. ;

Gibbs, Peter ;

Le, Dung ;

Giuntoli, Robert L. ;

Goggins, Michael ;

Hogarty, Michael D. ;

Holdhoff, Matthias ;

Hong, Seung-Mo ;

Jiao, Yuchen ;

Juhl, Hartmut H. ;

Kim, Jenny J. ;

Siravegna, Giulia ;

Laheru, Daniel A. ;

Lauricella, Calogero ;

Lim, Michael ;

Lipson, Evan J. ;

Marie, Suely Kazue Nagahashi ;

Netto, George J. ;

Oliner, Kelly S. ;

Olivi, Alessandro ;

Olsson, Louise ;

Riggins, Gregory J. ;

Sartore-Bianchi, Andrea ;

Schmidt, Kerstin ;

Shih, Ie-Ming ;

Oba-Shinjo, Sueli Mieko ;

Siena, Salvatore ;

Theodorescu, Dan ;

Tie, Jeanne ;

Harkins, Timothy T. ;

Veronese, Silvio ;

Wang, Tian-Li ;

Weingart, Jon D. .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

[7]

Bridgewater JA, 2020, LANCET ONCOL, V21, P398, DOI [10.1016/S1470-2045(19)30798-3, 10.1016/51470-2045(19)30798-3]

[8] Caution Is Required Before Recommending Routine Carcinoembryonic Antigen and Imaging Follow-Up for Patients With Early-Stage Colon Cancer [J].

Chao, Michael ;

Gibbs, Peter .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :e279-e280

[9] ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper [J].

Dasari, Arvind ;

Morris, Van K. ;

Allegra, Carmen J. ;

Atreya, Chloe ;

Benson, Al B., III ;

Boland, Patrick ;

Chung, Ki ;

Copur, Mehmet S. ;

Corcoran, Ryan B. ;

Deming, Dustin A. ;

Dwyer, Andrea ;

Diehn, Maximilian ;

Eng, Cathy ;

George, Thomas J. ;

Gollub, Marc J. ;

Goodwin, Rachel A. ;

Hamilton, Stanley R. ;

Hechtman, Jaclyn F. ;

Hochster, Howard ;

Hong, Theodore S. ;

Innocenti, Federico ;

Iqbal, Atif ;

Jacobs, Samuel A. ;

Kennecke, Hagen F. ;

Lee, James J. ;

Lieu, Christopher H. ;

Lenz, Heinz-Josef ;

Lindwasser, O. Wolf ;

Montagut, Clara ;

Odisio, Bruno ;

Ou, Fang-Shu ;

Porter, Laura ;

Raghav, Kanwal ;

Schrag, Deborah ;

Scott, Aaron J. ;

Shi, Qian ;

Strickler, John H. ;

Venook, Alan ;

Yaeger, Rona ;

Yothers, Greg ;

You, Y. Nancy ;

Zell, Jason A. ;

Kopetz, Scott .

NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (12) :757-770

[10] Detection and quantification of mutations in the plasma of patients with colorectal tumors [J].

Diehl, F ;

Li, M ;

Dressman, D ;

He, YP ;

Shen, D ;

Szabo, S ;

Diaz, LA ;

Goodman, SN ;

David, KA ;

Juhl, H ;

Kinzler, KW ;

Vogelstein, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (45) :16368-16373

← 1 2 3 4 5 →